deltatrials
Recruiting NA INTERVENTIONAL 1-arm NCT06171230

Eye Movement Desensitization and Reprocessing (EMDR) as a Treatment for Chronic Painful Diabetic Peripheral Neuropathy (EMDR4CPDN)

Sponsor: Dijklander Ziekenhuis

Updated 4 times since 2024 Last updated: Mar 11, 2024 Started: Mar 1, 2024 Primary completion: Mar 31, 2025 Completion: Mar 31, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06171230, this NA trial focuses on Diabetes Mellitus and Neuropathic Pain and remains actively recruiting participants. Sponsored by Dijklander Ziekenhuis, it has been updated 4 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2024 – ~Apr 2024 · 3 months · monthly snapshotNot Yet Recruiting~Apr 2024 – ~Jul 2024 · 3 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshotRecruiting

Change History

4 versions recorded
  1. Sep 2024 — Present [monthly]

    Recruiting NA

  2. Jul 2024 — Sep 2024 [monthly]

    Recruiting NA

  3. Apr 2024 — Jul 2024 [monthly]

    Recruiting NA

    Status: Not Yet RecruitingRecruiting

  4. Jan 2024 — Apr 2024 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Dijklander Ziekenhuis
Data source: Dijklander Ziekenhuis

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations